Boston and Thoratec hold their ground despite troubles while Zimmer exceeds expectations
This article was originally published in Clinica
American Medical Systems (AMS) saw its second quarter and half year profits boosted by 33% and 40%, respectively. The Minneapolis company attributed revenue growth to strong sales of its women continence products, which increased 52% compared with the same period last year, as well as male continence products, which showed a healthy growth of 17%. Erectile restoration, which accounts for the largest segment of AMS' men's health product line, was flat compared to last year's second quarter, but the company is expecting it to gather momentum, following the recent FDA clearance of the AMS 700 tactile pump. In addition, Minneapolis-based AMS is hoping the acquisition of TherMatrx (see Clinica No 1113, p 13) will provide another growth engine and the means to expand into the high-growth, in-office benign prostatic hyperplasia market.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.